Get the Stockscreener App
3.1584
7.20%
-0.245
Impact BioMedical, Inc. Stock (IBO) Forecast
The Impact BioMedical, Inc. (IBO) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $2.6467, representing a -16.20% decrease from the current price of $3.1584. The highest analyst price target is $3.48, and the lowest is $1.8134.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month IBO Price Target
Average 3.7378
(+18.34% Upside)
Is Impact BioMedical, Inc. (IBO) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 22.92 | Buy |
| STOCH(9,6) | 7.626 | Buy |
| STOCHRSI(14) | 2.4968 | Buy |
| MACD(12,26) | -0.6666 | Sell |
| ADX(14) | 29.39 | Sell |
| William %R | -84.83 | Buy |
| CCI(14) | -87.16 | Neutral |
Buy: 4
Sell: 2
Neutral: 1
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
4.2252
Sell
|
4.1673
Sell
|
| MA20 |
5.1789
Sell
|
4.7797
Sell
|
| MA50 |
5.6183
Sell
|
5.4236
Sell
|
| MA100 |
5.8986
Sell
|
5.8527
Sell
|
| MA200 |
6.4135
Sell
|
6.2001
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, IBO could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 12 signaling Sell signals and 1 Neutral signals. This might not be a good time to consider opening new positions on IBO, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 22.92 indicates that IBO is oversold. This indicates that IBO price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 7.626 indicates that IBO is oversold. This indicates that IBO price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 2.4968 indicates that IBO is oversold. This suggests that IBO price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 29.39 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -87.16 indicates that IBO is still oversold but not to an extreme extent.
Long-term IBO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Impact BioMedical, Inc. financial reports and earnings history, Impact BioMedical, Inc. (IBO) stock could reach $2.0765 by 2030, $50.44 by 2040 and $77.26 by 2050. See the projected annual prices until 2050 of the Impact BioMedical, Inc. stock below:
- Impact BioMedical, Inc. (IBO) is expected to reach an average price of $11.13 in 2035, with a high prediction of $12.35 and a low estimate of $11.38. This indicates an $252.30% rise from the last recorded price of $3.1584.
- Impact BioMedical, Inc. (IBO) stock is projected to chart a bullish course in 2040, with an average price target of $50.47, representing an $1,498% surge from its current level. The forecast ranges from a conservative $18.34 to a sky-high $50.44.
- Our analysts predict Impact BioMedical, Inc. (IBO) to jump 1,990% by 2045, soaring from $66.48 to an average price of $66.02, potentially reaching $67.07. While $66.48 is the low estimate, the potential upside is significant.
- Impact BioMedical, Inc. (IBO) stock is expected to climb by 2050, reaching an average of $75.75, a $2,298% jump from its current level. However, a wide range of estimates exists, with high and low targets of $77.26 and $75.77, respectively, highlighting the market's uncertainty.
Impact BioMedical, Inc. Stock (IBO) Year by Year Forecast
Impact BioMedical, Inc. Stock (IBO) Price Forecast for 2026
The predicted value for Impact BioMedical, Inc. (IBO) in 2026 is set at an average of $5.6134. Estimates vary from a peak of $10.47 to a trough of $0.7521, indicating an +77.73% surge from the present price of $3.1584.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $2.1302 | $1.8134 | $3.48 | -32.55% |
| December, 2026 | $1.1892 | $0.7521 | $2.8239 | -62.35% |
Impact BioMedical, Inc. Stock (IBO) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Impact BioMedical, Inc. (IBO) is $3.7749, with a high forecast of $6.7234 and a low forecast of $0.8265. This indicates an +19.52% increase from the last price of $3.1584.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.0315 | $1.00 | $3.8899 | -35.68% |
| February, 2027 | $1.6256 | $1.3404 | $2.7311 | -48.53% |
| March, 2027 | $1.7099 | $0.8265 | $2.6277 | -45.86% |
| April, 2027 | $6.1841 | $1.2509 | $6.7234 | +95.80% |
| May, 2027 | $4.7098 | $3.0371 | $5.5612 | +49.12% |
| June, 2027 | $4.6914 | $4.309 | $5.576 | +48.54% |
| July, 2027 | $4.0912 | $2.8262 | $4.9266 | +29.53% |
| August, 2027 | $3.1228 | $2.674 | $4.8071 | -1.13% |
| September, 2027 | $2.7763 | $2.306 | $3.5428 | -12.10% |
| October, 2027 | $3.1327 | $2.5395 | $3.7044 | -0.81% |
| November, 2027 | $3.4526 | $3.1441 | $5.7017 | +9.31% |
| December, 2027 | $1.3495 | $1.1962 | $3.9784 | -57.27% |
Impact BioMedical, Inc. Stock (IBO) Price Forecast for 2028
In 2028, Impact BioMedical, Inc. (IBO) is projected to reach an average price of $1.5235, with a high projection of $3.0254 and a low estimate of $0.0217. This indicates an -51.76% fall from the last price of $3.1584.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.9062 | $1.7158 | $1.4784 | -39.65% |
| February, 2028 | $3.0045 | $2.0934 | $1.8897 | -4.87% |
| March, 2028 | $2.5668 | $3.0161 | $3.0254 | -18.73% |
| April, 2028 | $1.7846 | $2.5216 | $1.7846 | -43.50% |
| May, 2028 | $1.9165 | $2.1144 | $1.8094 | -39.32% |
| June, 2028 | $0.9833 | $2.2198 | $2.9722 | -68.87% |
| July, 2028 | $0.4097 | $0.0396 | $2.5247 | -87.03% |
| August, 2028 | $1.9049 | $0.2503 | $2.1917 | -39.69% |
| September, 2028 | $0.5531 | $0.1265 | $1.9512 | -82.49% |
| October, 2028 | $0.093 | $0.2443 | $1.7899 | -97.06% |
| November, 2028 | $0.2706 | $0.0217 | $0.9706 | -91.43% |
| December, 2028 | $0.6793 | $0.0414 | $0.9922 | -78.49% |
Impact BioMedical, Inc. Stock (IBO) Price Forecast for 2029
The 2029 price forecast for Impact BioMedical, Inc. Stock (IBO) is $3.8021 on average, with a high prediction of $7.4646 and a low estimate of $0.1396. This represents an +20.38% increase from the previous price of $3.1584.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.1493 | $0.4038 | $3.3267 | -63.61% |
| February, 2029 | $1.0287 | $0.9736 | $3.1316 | -67.43% |
| March, 2029 | $6.1666 | $0.1396 | $6.3572 | +95.24% |
| April, 2029 | $7.1153 | $6.5237 | $6.401 | +125.28% |
| May, 2029 | $7.6893 | $7.2932 | $7.4646 | +143.46% |
| June, 2029 | $6.4801 | $6.8171 | $6.9964 | +105.17% |
| July, 2029 | $6.1252 | $6.2325 | $5.9487 | +93.93% |
| August, 2029 | $5.976 | $6.1087 | $5.6633 | +89.21% |
| September, 2029 | $1.1348 | $5.6641 | $5.485 | -64.07% |
| October, 2029 | $2.1504 | $2.7183 | $2.952 | -31.91% |
| November, 2029 | $1.8018 | $1.6745 | $1.4335 | -42.95% |
| December, 2029 | $1.6691 | $2.6156 | $2.6384 | -47.15% |
Impact BioMedical, Inc. Stock (IBO) Price Forecast for 2030
Impact BioMedical, Inc. Stock (IBO) is expected to reach an average price of $6.5242 in 2030, with a high forecast of $11.90 and a low forecast of $1.1444. This signifies an +106.57% surge from the last price of $3.1584.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $2.5447 | $2.5699 | $2.0765 | -19.43% |
| February, 2030 | $2.5242 | $2.7135 | $2.3326 | -20.08% |
| March, 2030 | $1.8009 | $1.8476 | $1.9361 | -42.98% |
| April, 2030 | $1.0223 | $1.1444 | $1.3251 | -67.63% |
| May, 2030 | $2.7584 | $1.1447 | $1.7018 | -12.66% |
| June, 2030 | $11.27 | $11.33 | $11.26 | +256.79% |
| July, 2030 | $12.07 | $11.43 | $11.05 | +282.04% |
| August, 2030 | $11.26 | $11.71 | $11.90 | +256.57% |
| September, 2030 | $10.10 | $10.35 | $10.11 | +219.77% |
| October, 2030 | $9.7859 | $10.19 | $9.954 | +209.84% |
| November, 2030 | $6.5191 | $9.9568 | $9.3142 | +106.41% |
| December, 2030 | $6.634 | $7.0833 | $6.5197 | +110.04% |
1.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):